← Back to Search

Radiation

1 for Dementia

Phase 1
Waitlist Available
Led By Kwasi Donyina, Ph.D.
Research Sponsored by GAAD Medical Research Institute Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Persons age 2 or older, with dementia, Alzheimer's, Huntington's disease, Parkinson's disease, Down's syndrome, multiple sclerosis or stroke
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial is a preliminary study to determine the use of far infrared radiation for the treatment of dementia and other mental sickness.

Eligible Conditions
  • Dementia

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The primary end point is to determine the therapeutic effects of far infrared radiation on dementia.
Secondary outcome measures
The secondary end point of the study is to evaluate the therapeutic effects of far infrared radiation on other related mental illness including Alzheimer's, multiple sclerosis and stroke rehabilitation.

Trial Design

1Treatment groups
Experimental Treatment
Group I: 1Experimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

GAAD Medical Research Institute Inc.Lead Sponsor
21 Previous Clinical Trials
91 Total Patients Enrolled
1 Trials studying Dementia
Kwasi Donyina, Ph.D.Principal InvestigatorGAAD Medical Research Institute Inc.
13 Previous Clinical Trials
50 Total Patients Enrolled
Ken Nedd, M.D.Study DirectorGAAD Medical Research Institute Inc.
19 Previous Clinical Trials
89 Total Patients Enrolled
1 Trials studying Dementia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~0 spots leftby May 2025